Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors

被引：0
作者：
Edward Sausville
Patricia LoRusso
Michael Carducci
Judith Carter
Mary F. Quinn
Lisa Malburg
Nilofer Azad
David Cosgrove
Richard Knight
Peter Barker
Sonya Zabludoff
Felix Agbo
Patricia Oakes
Adrian Senderowicz
机构：
[1] University of Maryland,Marlene and Stewart Greenebaum Cancer Center
[2] Wayne State University School of Medicine,Karmanos Cancer Center
[3] Johns Hopkins Medical Institutions,Sidney Kimmel Comprehensive Cancer Center
[4] AstraZeneca,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2014年 / 73卷
关键词：
AZD7762; Chk1; Solid tumors; Phase I; Safety; Pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：539 / 549
页数：10
相关论文
共 50 条
[31]   Phase I/Ib dose-escalation study of aveluma in Chinese patients with advanced solid tumors [J].
Wu, Yi-Long ;
Cheng, Ying ;
Chen, Huajun ;
Tu, Haiyan ;
Xu, Chongrui ;
Wang, Zhen ;
Liu, Ying ;
Xin, Ying ;
Lou, Haizhou ;
Wang, Wei ;
Chin, Kevin ;
Li, Dandan ;
Zhao, Di ;
Gao, Yanfei ;
Xu, Wenping ;
Pan, Hongming .
FUTURE ONCOLOGY, 2022,
[32]   A phase I dose-escalation and pharmacokinetic study of enzastaurin and erlotinib in patients with advanced solid tumors [J].
Padda, Sukhmani K. ;
Krupitskaya, Yelena ;
Chhatwani, Laveena ;
Fisher, George A. ;
Colevas, Alexander D. ;
Pedro-Salcedo, Melanie San ;
Decker, Rodney ;
Latz, Jane E. ;
Wakelee, Heather A. .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (04) :1013-1020
[33]   A phase I dose-escalation and pharmacokinetic study of enzastaurin and erlotinib in patients with advanced solid tumors [J].
Sukhmani K. Padda ;
Yelena Krupitskaya ;
Laveena Chhatwani ;
George A. Fisher ;
Alexander D. Colevas ;
Melanie San Pedro-Salcedo ;
Rodney Decker ;
Jane E. Latz ;
Heather A. Wakelee .
Cancer Chemotherapy and Pharmacology, 2012, 69 :1013-1020
[34]   Phase I/Ib dose-escalation study of avelumab in Chinese patients with advanced solid tumors [J].
Wu, Yi-Long ;
Cheng, Ying ;
Chen, Huajun ;
Tu, Haiyan ;
Xu, Chongrui ;
Wang, Zhen ;
Liu, Ying ;
Xin, Ying ;
Lou, Haizhou ;
Wang, Wei ;
Chin, Kevin ;
Li, Dandan ;
Zhao, Di ;
Gao, Yanfei ;
Xu, Wenping ;
Pan, Hongming .
FUTURE ONCOLOGY, 2022, 18 (17) :2053-2062
[35]   Phase I Dose-Escalation Study of the Multikinase Inhibitor Lenvatinib in Patients with Advanced Solid Tumors and in an Expanded Cohort of Patients with Melanoma [J].
Hong, David S. ;
Kurzrock, Razelle ;
Wheler, Jennifer J. ;
Naing, Aung ;
Falchook, Gerald S. ;
Fu, Siqing ;
Kim, Kevin B. ;
Davies, Michael A. ;
Nguyen, Ly M. ;
George, Goldy C. ;
Xu, Lucy ;
Shumaker, Robert ;
Ren, Min ;
Mink, Jennifer ;
Bedell, Cynthia ;
Andresen, Corina ;
Sachdev, Pallavi ;
O'Brien, James P. ;
Nemunaitis, John .
CLINICAL CANCER RESEARCH, 2015, 21 (21) :4801-4810
[36]   A Phase I Dose-Escalation Study of LY3405105, a Covalent Inhibitor of Cyclin-Dependent Kinase 7, Administered to Patients With Advanced Solid Tumors [J].
Garralda, Elena ;
Schram, Alison M. ;
Bedard, Philippe L. ;
Schwartz, Gary K. ;
Yuen, Eunice ;
McNeely, Samuel C. ;
Ribeiro, Silvia ;
Cunningham, Jason ;
Wang, Yi ;
Urunuela, Arantxa ;
Xu, Xiaojian ;
LoRusso, Patricia .
ONCOLOGIST, 2024, 29 (01) :e131-e140
[37]   A phase 1 dose escalation study of BI 831266, an inhibitor of Aurora kinase B, in patients with advanced solid tumors [J].
Dittrich, Christian ;
Fridrik, Michael A. ;
Koenigsberg, Robert ;
Lee, Chooi ;
Goeldner, Rainer-Georg ;
Hilbert, James ;
Greil, Richard .
INVESTIGATIONAL NEW DRUGS, 2015, 33 (02) :409-422
[38]   Phase I Dose Escalation Study of Gemcitabine plus Irinotecan in Advanced Solid Tumors [J].
Dugan, Elizabeth ;
Truax, Roxanne ;
Meadows, Kellen L. ;
Blobe, Gerald C. ;
Morse, Michael A. ;
Fernando, Nishan H. ;
Gockerman, Jon P. ;
Petros, William P. ;
Hurwitz, Herbert I. .
ANTICANCER RESEARCH, 2009, 29 (12) :5149-5153
[39]   Phase Ⅰ dose-escalation and expansion study of PARP inhibitor,fluzoparib(SHR3162), in patients with advanced solid tumors [J].
Huiping Li ;
Rongrui Liu ;
Bin Shao ;
Ran Ran ;
Guohong Song ;
Ke Wang ;
Yehui Shi ;
Jihong Liu ;
Wenjing Hu ;
Fu Chen ;
Xiaoran Liu ;
Gairong Zhang ;
Chuanhua Zhao ;
Ru Jia ;
Quanren Wang ;
Hope SRugo ;
Yifan Zhang ;
Guangze Li ;
Jianming Xu .
Chinese Journal of Cancer Research, 2020, 32 (03) :370-384
[40]   A phase I, first-in-human dose-escalation study of amuvatinib, a multi-targeted tyrosine kinase inhibitor, in patients with advanced solid tumors [J].
Tibes, Raoul ;
Fine, Gil ;
Choy, Gavin ;
Redkar, Sanjeev ;
Taverna, Pietro ;
Oganesian, Aram ;
Sahai, Amarpal ;
Azab, Mohammad ;
Tolcher, Anthony W. .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (02) :463-471
12345